Biofinity® toric multifocal

Product specs

Offer your astigmatic patients remarkable vision near, far and in between.1 With Biofinity®, you’re golden.

Features

  • Over 200,000 unique prescription options to provide correction for 99.6% of astigmatic presbyopes.1,2
  • Optimized Toric Lens Geometry™, the same proven toric design as Biofinity® toric, the #1 most prescribed toric lens on the market.3
  • Balanced Progressive Technology® provides remarkable vision at all distances—near, intermediate, and far away.
  • Aquaform® Technology locks in moisture providing proven, incredible comfort.4
  • For every Biofinity® lens you fit, we partner with Plastic Bank® to fund the collection, processing, and conversion of an equal amount of plastic, making Biofinity® net plastic neutral.*†5

 

These highly customized, made-to-order lenses are predominantly manufactured at CooperVision’s technologically advanced facility in Scottsville, N.Y. so most U.S. orders reach customers within a week.

Toric multifocal fitting made simple

CooperVision Biofinity® toric multifocal contact lenses combine the comfort and proven optical designs of Biofinity® toric—the most prescribed toric lens on the market—and Biofinity® multifocal.3

With more than 200,000 unique prescription options (that’s 34x the competition)2,6 you can fit nearly 100% of your astigmatic presbyopes1 with a 93% success rate on initial fitting when using the fitting guide.7

Gone are the days of complicated multifocal lens fittings. The OptiExpert® fitting app saves valuable chair time by taking the guesswork out of selecting the right lenses for your patients.8-10 Download the OptiExpert fitting app on the App Store, Google Play, or access it through your web browser. And thanks to CooperVision’s made-to-order advantage, these ship to patients within 10 days. 

 

Lens Technology

Product Details

H20 content
48%
Replacement schedule
Monthly
Oxygen transmissibility
116 Dk/t (at -3.00D)
Technology
D Lens, N Lens
Base curve
8.7
Diameter
14.5
Sphere power
-10.00 to -6.50; 0.50 steps
-6.00 to +6.00; 0.25 steps
+6.50 to +10.00; 0.50 steps
Cylinder power
-0.75 to -5.75; 05.0 steps
Axis
5º - 180º, 5º increments
Add power
+1.00
+1.50
+2.00
+2.50

* Biofinity is defined as orders and includes Biofinity sphere, Biofinity Energys, Biofinity toric, Biofinity multifocal, Biofinity XR, Biofinity XR Toric, Biofinity toric multifocal product(s) sold and distributed by CooperVision in the US.
† Amount is defined as weight. Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in Biofinity orders in a specified time period. Biofinity plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).

References:

1.    CVI data on file, 2020. Rx coverage database; 42 to 70 years ≥0.75DC.
2.    CVI data on file, 2019. Based on total number of prescription option combinations (for sphere, cylinder, axis and add - including D & N combinations) manufactured.
3.    CVI data on file, 2023. US industry reports and internal estimates.
4.    CVI data on file, 2024.
5.    CVI Data on file, 2022.
6.    CVI data on file, 2022. Bausch + Lomb product specifications, US February 2022. Based on total number of prescription option combinations (for sphere, cylinder, axis and add - including D & N combinations) manufactured; Biofinity® toric multifocal is made-to-order; ULTRA® Multifocal for Astigmatism is stocked.
7.    CVI Data on file 2018. Non-dispensing, subject masked, randomized, bilateral, cross-over short-term clinical evaluation. 27 astigmatic, presbyopic soft CL wearers at 2 sites (UK & US) fitted using CVI fit guide.
8.    Luensmann D et al. Toric lens fitting success supported by an online fitting App. Poster to be presented at NCC/BCLA 2020.
9.    CVI data on file, 2020. Kubic Online Survey of ECPs in US, Germany, Spain, Japan and South Korea. Total weighted sample n = 549.
10.    CVI data on file 2019. Retrospective analysis; N=55 subjects (110 eyes); DV Rx +1.25D to -3.25D, add powers +1.25 to +2.50DS.